Allergan plc Ordinary Shares (AGN) reported quarterly earnings results on Monday, Aug-8-2016. The company said it had a profit of $3.35 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.03. Analysts had a consensus of $3.32. The company posted revenue of $3709.00 million in the period, compared to analysts expectations of $3977.46 million. The company’s revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.41 EPS.
Many Wall Street Analysts have commented on Allergan plc Ordinary Shares. Company shares were Reiterated by Mizuho on Aug 5, 2016 to “Neutral”, Firm has raised the Price Target to $ 246 from a previous price target of $232 .Company shares were Reiterated by Leerink Partners on Jul 27, 2016 to “Outperform”, Firm has raised the Price Target to $ 294 from a previous price target of $272 .Credit Suisse Initiated Allergan plc Ordinary Shares on Jul 25, 2016 to “Outperform”, Price Target of the shares are set at $327.
Allergan plc Ordinary Shares opened for trading at $254 and hit $254.59 on the upside on Friday, eventually ending the session at $253.85, with a gain of 0.16% or 0.4 points. The heightened volatility saw the trading volume jump to 30,85,021 shares. Company has a market cap of $100,412 M.
In a different news, on Jun 6, 2016, Maria Teresa Hilado (CFO) purchased 661 shares at $241.57 per share price. According to the SEC, on May 12, 2016, Nesli Basgoz (director) sold 459 shares at $225.10 per share price. On Aug 24, 2015, Brent L Saunders (CEO) purchased 1,000 shares at $301.94 per share price, according to the Form-4 filing with the securities and exchange commission.